These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23996830)

  • 1. Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes.
    Devulapally R; Paulmurugan R
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2014; 6(1):40-60. PubMed ID: 23996830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.
    Zhang P; An K; Duan X; Xu H; Li F; Xu F
    Drug Discov Today; 2018 Apr; 23(4):900-911. PubMed ID: 29373841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theranostic Nanoparticles for RNA-Based Cancer Treatment.
    Revia RA; Stephen ZR; Zhang M
    Acc Chem Res; 2019 Jun; 52(6):1496-1506. PubMed ID: 31135134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle Delivery Systems for DNA/RNA and their Potential Applications in Nanomedicine.
    Shen H; Huang X; Min J; Le S; Wang Q; Wang X; Dogan AA; Liu X; Zhang P; Draz MS; Xiao J
    Curr Top Med Chem; 2019; 19(27):2507-2523. PubMed ID: 31775591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
    Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X
    J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
    Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
    Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy.
    Kara G; Parlar A; Cakmak MC; Cokol M; Denkbas EB; Bakan F
    Colloids Surf B Biointerfaces; 2020 Dec; 196():111340. PubMed ID: 32956996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
    Moritz M; Geszke-Moritz M
    Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction-responsive polymers for drug delivery in cancer therapy-Is there anything new to discover?
    Monteiro PF; Travanut A; Conte C; Alexander C
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Mar; 13(2):e1678. PubMed ID: 33155421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers.
    Sun H; Yarovoy I; Capeling M; Cheng C
    Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
    Ku SH; Kim K; Choi K; Kim SH; Kwon IC
    Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How nanotechnology can enhance docetaxel therapy.
    Zhang L; Zhang N
    Int J Nanomedicine; 2013; 8():2927-41. PubMed ID: 23950643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric core-shell nanoparticles for therapeutics.
    Yang YY; Wang Y; Powell R; Chan P
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):557-62. PubMed ID: 16700894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted Delivery of Drugs and Genes Using Polymer Nanocarriers for Cancer Therapy.
    Xia W; Tao Z; Zhu B; Zhang W; Liu C; Chen S; Song M
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo.
    Shi P; Aluri S; Lin YA; Shah M; Edman M; Dhandhukia J; Cui H; MacKay JA
    J Control Release; 2013 Nov; 171(3):330-8. PubMed ID: 23714121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical evaluation of biodegradable polymers used in nanodrugs.
    Marin E; Briceño MI; Caballero-George C
    Int J Nanomedicine; 2013; 8():3071-90. PubMed ID: 23990720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoengineering Branched Star Polymer-Based Formulations: Scope, Strategies, and Advances.
    Yong HW; Kakkar A
    Macromol Biosci; 2021 Aug; 21(8):e2100105. PubMed ID: 34117840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.